Page last updated: 2024-10-21

pk 11195 and Psychotic Disorders

pk 11195 has been researched along with Psychotic Disorders in 1 studies

PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine

Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Di Biase, MA1
Zalesky, A1
O'keefe, G1
Laskaris, L1
Baune, BT1
Weickert, CS1
Olver, J1
McGorry, PD1
Amminger, GP1
Nelson, B1
Scott, AM1
Hickie, I1
Banati, R1
Turkheimer, F1
Yaqub, M1
Everall, IP1
Pantelis, C1
Cropley, V1

Other Studies

1 other study available for pk 11195 and Psychotic Disorders

ArticleYear
PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia.
    Translational psychiatry, 2017, 08-29, Volume: 7, Issue:8

    Topics: Adolescent; Adult; Brain; Carbon Radioisotopes; Female; Humans; Isoquinolines; Male; Microglia; Posi

2017